Skip to main
ABL
ABL logo

ABL Stock Forecast & Price Target

ABL Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Abacus Global Management Inc. has provided a positive outlook with its reiterated guidance for 2025 adjusted net income projected at $70 million to $78 million, indicating a nearly 60% growth from previous levels. The company's management expressed confidence in its ability to perform well during market volatility, as individuals may seek liquidity through strategies such as monetizing life insurance policies. This strategic positioning, combined with strong recent results, suggests a favorable momentum for the stock's performance moving forward.

Bears say

Abacus Global Management Inc. is facing challenges in its financial performance, particularly due to increased competition within the alternative asset management sector, which is straining its margins across all segments. The company's reliance on technology innovations has not yet yielded a sufficient return on investment, leading to sluggish growth in revenues as operational costs continue to rise sharply. Additionally, its narrow operational focus within the United States limits its market expansion opportunities, potentially hindering long-term sustainability in a rapidly evolving financial landscape.

ABL has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Abacus Life Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Abacus Life Inc (ABL) Forecast

Analysts have given ABL a Buy based on their latest research and market trends.

According to 4 analysts, ABL has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Abacus Life Inc (ABL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.